Health-care companies rose as investors sloughed off concerns about a mixed earnings season for the sector.
Brazilian health regulator Anvisa said it has serious doubts about Sputnik V's safety and efficacy, blaming Russia's lack of experience and defensive attitude for making it harder to approve the Covid-19 vaccine for use in Latin America's biggest country.
Biotech concern Moderna agreed to supply 34 million doses of its Covid-19 vaccine to an international program that distributes free shots to poorer countries.
The Blue Cross Blue Shield Association, which includes large corporations such as Anthem and Health Care Service, dropped a rule that limited competition among its member insurers, moving to implement a key aspect of an antitrust settlement the companies reached last year with customers.
Write to Rob Curran at email@example.com
(END) Dow Jones Newswires